Thought Leadership
 
Email Page
Little Impact Post-Arthrex for Biologic Patents at the PTAB
December 3, 2019
Stacie Ropka, Drew Hillier, and Gabriella McIntyre
The Center for Biosimilars

Axinn partner Stacie Ropka and associates Drew Hillier and Gabriella McIntyre authored The Center for Biosimilars article, "Little Impact Post-Arthrex for Biologic Patents at the PTAB."

Click here to access the article.